Eleven dangerous synthetic cannabinoids tested against THC

This study examined 11 synthetic cannabinoids flagged by the DEA as dangerous substances, comparing their behavioral effects to delta-9-tetrahydrocannabinol (THC) in rodent models. The synthetic compounds—including ADB-BUTINACA, ADB-HEXINACA, ADB-4en-PINACA, ADB-FUBIATA, 4F-MDMB-BICA, 4F-ABUTINACA, FUB-144, FUB-AKB-48, 5F-EMB-PICA, 5Cl-AKB-48, and MDA-19—were tested across multiple behavioral measures including locomotion, drug discrimination, and potency. These synthetic cannabinoids are sold as legal alternatives to cannabis but have been linked to severe adverse effects including hallucinations and death.

The research used established rodent behavioral pharmacology methods to characterize how these compounds affect movement, perception, and overall potency compared to natural THC. Understanding the relative potency and behavioral profiles of these substances is critical for public health, as synthetic cannabinoids continue to flood the market despite regulations. The findings provide important baseline data for toxicology and help explain why these compounds produce such dangerous effects compared to traditional cannabis products.

This work has significant implications for harm reduction and drug policy. By systematically comparing synthetic cannabinoids to THC, researchers can better predict the risks associated with new compounds entering the market and inform both medical professionals treating overdoses and policymakers developing regulations around these substances.